Flow Cytometry Core
流式细胞术核心
基本信息
- 批准号:10628881
- 负责人:
- 金额:$ 18.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-01 至 2028-02-29
- 项目状态:未结题
- 来源:
- 关键词:Applications GrantsCancer BiologyCancer CenterCell SeparationConsultCore FacilityDataData AnalysesData CollectionDevelopmentDiseaseEducationEnsureEquipmentExperimental DesignsFacultyFee-for-Service PlansFlow CytometryFundingFutureGoalsGrantGrowthHealthHumanHuman ResourcesImageInfrastructureInstitutionMaintenanceManuscriptsMissionPersonsPhasePreparationPrincipal InvestigatorProtocols documentationPublicationsResearchResearch PersonnelResource SharingSamplingScheduleScientistSecureServicesSiteSortingStructureTechniquesTrainingTraining and EducationTranslatingUnited States National Institutes of HealthUpdateWagesWorkbasedesignequipment acquisitionexperienceinstrumentinstrumentationnoveloperationresearch facultywebinar
项目摘要
Abstract
A key component of Phase III CoBRE funding for the Center for Cancer Biology Research (CCBR) is support of
the Flow Cytometry Core (Core B). This core, established in 2011 with the initiation of Phase I, is extensively
used by CCBR investigators, those at Sanford Research at large, investigators from regional institutions, and
recently by contractual users. The Core provides state-of-the-art equipment for flow cytometry, cell sorting, and
related sample preparation. The Flow Core staff provides a wide array of services in terms of instrumentation,
training, and experimental design. This allows investigators to obtain high quality data to support publications
and grant proposals. For Phase III, the Core presents a feasible plan for transitioning to independence. This plan
includes a fee-for-services schedule. Also, the Core will continue to expand its services through the acquisition
of state-of-the-art instrumentation and a growing user base, including additional clientele from regional
institutions and contractual arrangements. Already, the reputation of the Core's quality work and quick
turnaround has expanded regional and contractual usage. Based on this growth and substantial institutional
support through personnel salaries and equipment purchases and maintenance, self-sufficiency will be attained.
following Phase III support.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Pilar de la Puente其他文献
Pilar de la Puente的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Pilar de la Puente', 18)}}的其他基金
Role of extracellular matrix remodeling on high-grade serous ovarian carcinoma immune evasion
细胞外基质重塑在高级别浆液性卵巢癌免疫逃避中的作用
- 批准号:
10425569 - 财政年份:2022
- 资助金额:
$ 18.56万 - 项目类别:
Role of extracellular matrix remodeling on high-grade serous ovarian carcinoma immune evasion
细胞外基质重塑在高级别浆液性卵巢癌免疫逃避中的作用
- 批准号:
10573243 - 财政年份:2022
- 资助金额:
$ 18.56万 - 项目类别:
相似海外基金
Determining the impact of ancestry on oropharyngeal cancer biology and treatment response.
确定血统对口咽癌生物学和治疗反应的影响。
- 批准号:
10562456 - 财政年份:2023
- 资助金额:
$ 18.56万 - 项目类别:
Radiation Oncology at the Interface of Pediatric Cancer Biology and Data Science
儿科癌症生物学和数据科学交叉领域的放射肿瘤学
- 批准号:
10712290 - 财政年份:2023
- 资助金额:
$ 18.56万 - 项目类别:
Graduate Program in Cancer Biology Training at Emory University
埃默里大学癌症生物学培训研究生课程
- 批准号:
10768333 - 财政年份:2023
- 资助金额:
$ 18.56万 - 项目类别:
Utilizing Multi-omics to Facilitate Cancer Biology Research
利用多组学促进癌症生物学研究
- 批准号:
10733768 - 财政年份:2023
- 资助金额:
$ 18.56万 - 项目类别:
Massive single cell proteomics for cancer biology
用于癌症生物学的大规模单细胞蛋白质组学
- 批准号:
10707321 - 财政年份:2022
- 资助金额:
$ 18.56万 - 项目类别:














{{item.name}}会员




